You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Penpulimab Injection

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Cancer Trial in Chengdu, Hangzhou (TQB2223 injection+ Penpulimab Injection)

Recruiting
  • Advanced Cancer
  • TQB2223 injection+ Penpulimab Injection
  • Chengdu, Sichuan, China
  • +1 more
Jun 7, 2023

Recurrent Squamous Cell Carcinoma of the Head and Neck, Metastatic Squamous Cell Carcinoma Trial in China (TQB2618 injection,

Not yet recruiting
  • Recurrent Squamous Cell Carcinoma of the Head and Neck
  • Metastatic Squamous Cell Carcinoma
  • TQB2618 injection, Penpulimab injection, Paclitaxel, Cisplatin or Carboplatin
  • Penpulimab injection, Paclitaxel, Cisplatin or Carboplatin
  • Lanzhou, Gansu, China
  • +11 more
Mar 23, 2023

Advanced Hepatocellular Carcinoma Trial in China (Penpulimab injection, TQB2618 injection, Anlotinib Hydrochloride Capsules)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Penpulimab injection
  • +2 more
  • Wuwei, Gansu, China
  • +7 more
Jul 27, 2023

Nasopharyngeal Carcinoma Trial in China (TQB2618 Injection, Pempulimab Injection, Cisplatin Injection, Gemcitabine Hydrochloride

Recruiting
  • Nasopharyngeal Carcinoma
  • TQB2618 Injection, Pempulimab Injection, Cisplatin Injection, Gemcitabine Hydrochloride Injection
  • +2 more
  • Guangzhou, Guangdong, China
  • +3 more
Nov 28, 2022

Advanced Esophageal Squamous Cell Carcinoma Trial in China (TQB2618 injection, Penpulimab injection, Paclitaxel, Cisplatin,

Not yet recruiting
  • Advanced Esophageal Squamous Cell Carcinoma
  • TQB2618 injection, Penpulimab injection, Paclitaxel, Cisplatin
  • +2 more
  • Tongling, Anhui, China
  • +9 more
Apr 18, 2023

Bladder Cancer Trial (Disitamab Vedotin for Injection,Penpulimab Injection)

Not yet recruiting
  • Bladder Cancer
  • Disitamab Vedotin for Injection,Penpulimab Injection
  • (no location specified)
Aug 2, 2022

Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Penpulimab injection, cisplatin, albumin-paclitaxel)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Penpulimab injection
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Ninth People's Hostipal, Shanghai Jiao Tong University
Oct 7, 2023

Colorectal Cancer Trial in China (TQB2618 injection, Penpulimab injection, Anlotinib HCl capsules)

Not yet recruiting
  • Colorectal Cancer
  • TQB2618 injection
  • +2 more
  • Fuyang, Anhui, China
  • +14 more
Aug 23, 2023

Advanced Solid Tumor Trial in Beijing (Inosine 0.2g orally 3 times/day, PD-1/PD-L1 inhibitor ,chemo/targeting)

Completed
  • Advanced Solid Tumor
  • Inosine 0.2g orally 3 times/day
  • PD-1/PD-L1 inhibitor ,chemotherapy/targeting
  • Beijing, Beijing, China
    Qin li
Mar 30, 2023

Carcinoma, Gastrointestinal Diseases, Stomach Cancer Trial (Anlotinib HCl capsule, Penpulimab Injection, XELOX)

Not yet recruiting
  • Carcinoma
  • +6 more
  • Anlotinib hydrochloride capsule
  • +2 more
  • (no location specified)
Aug 8, 2022

Relapsed/Refractory Lymphoma Trial in Chengdu (TQB2618 injection, Penpulimab injection)

Recruiting
  • Relapsed/Refractory Lymphoma
  • TQB2618 injection
  • Penpulimab injection
  • Chengdu, Sichuan, China
    Sichuan Cancer Hospital
Jun 1, 2022

Hepatocellular Carcinoma Trial in China (Anlotinib HCl capsules, Penpulimab injection, Anlotinib HCl capsules -matching ,

Recruiting
  • Hepatocellular Carcinoma
  • Anlotinib hydrochloride capsules, Penpulimab injection
  • Anlotinib hydrochloride capsules -matching placebo, Penpulimab injection -matching placebo
  • Bengbu, Anhui, China
  • +66 more
May 15, 2023

MGMT-Unmethylated Glioblastoma Trial in Nanjing (Anlotinib, AK105, Radiotherapy)

Recruiting
  • MGMT-Unmethylated Glioblastoma
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Aug 27, 2021

Head and Neck Tumors, Recurrent Disease, Metastatic Cancer Trial in Shanghai (Penpulimab combined with cetuximab)

Active, not recruiting
  • Head and Neck Neoplasms
  • +2 more
  • Penpulimab combined with cetuximab
  • Shanghai, China
    Department of Radiotherapy, Eye & ENT Hospital of Fudan Universi
Mar 1, 2022

Classic Hodgkin Lymphoma Trial (Concurrent penpulimab and AVD, Sequential penpulimab and AVD)

Not yet recruiting
  • Classic Hodgkin Lymphoma
  • Concurrent penpulimab and AVD
  • Sequential penpulimab and AVD
  • (no location specified)
Jul 10, 2023

Lung Cancer, Lung Carcinoma, Non Small Cell Lung Cancer Trial in Xinxiang (Anlotinib and Penpulimab)

Recruiting
  • Lung Cancer
  • +4 more
  • Anlotinib and Penpulimab
  • Xinxiang, Henan, China
    The First Affiliated Hospital of Xinxiang Medical College
May 16, 2022

Esophageal Squamous Cell Carcinoma Trial in Shanghai (Penpulimab Combined With CRT)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Penpulimab Combined With CRT
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Sep 28, 2022

Pheochromocytoma, Metastatic, Pheochromocytoma Malignant, Paraganglioma, Malignant Trial in Beijing (Penpulimab)

Recruiting
  • Pheochromocytoma, Metastatic
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
May 31, 2023

Nasopharyngeal Tumors Trial (The combination treatment of anlotinib, penpulimab and capecitabine.)

Not yet recruiting
  • Nasopharyngeal Neoplasms
  • The combination treatment of anlotinib, penpulimab and capecitabine.
  • (no location specified)
Apr 10, 2023

Breast Cancer Trial in Chengdu (Disitamab Vedotin, Penpulimab)

Not yet recruiting
  • Breast Cancer
  • Chengdu, Chengdu, Sichuan, China, China
    West China Hospital, Sichuan University
Feb 9, 2023

Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma Trial in Beijing (Anlotinib Hydrochloride

Not yet recruiting
  • Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma
  • Anlotinib Hydrochloride Capsule and Penpulimab
  • Beijing, Beijing, China
    YansongLin
Sep 25, 2023

Pancreatic Adenocarcinoma Metastatic Trial in Nanjing (Penpulimab, Anlotinib, Nab paclitaxel)

Recruiting
  • Pancreatic Adenocarcinoma Metastatic
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Sep 18, 2023

Hepatocellular Carcinoma Trial (TACE+penpulimab+anlotinib vs. penpulimab+anlotinib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • TACE+penpulimab+anlotinib vs. penpulimab+anlotinib
  • (no location specified)
Apr 18, 2022

Rectal Cancer, Locally Advanced Trial (radiation, drug, procedure)

Not yet recruiting
  • Rectal Cancer
  • Locally Advanced
  • Short-course radiotherapy
  • +3 more
  • (no location specified)
Oct 8, 2022

NSCLC Trial (Anlotinib Hydrochloride, penpulimab, SBRT)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Anlotinib Hydrochloride
  • +2 more
  • (no location specified)
Aug 2, 2022